Nucleus Network Information

Nucleus Network is the only global provider dedicated to early phase clinical trials, with units in Australia, the USA and the UK. Our unified network provides sponsors access to all three major regulatory markets through one trusted partner. With more than 2,500 early phase studies and 1,500 First in Human trials over 30 years, we are the most experienced early phase team worldwide. We are recognised for managing complex and adaptive designs with confidence, supported by proven scientific leadership and operational delivery. Alongside First in Human expertise, we conduct the full spectrum of clinical pharmacology studies, giving sponsors the depth, consistency and participant access to accelerate new medicines. One Network. Multiple Pathways. The Power of a Unified Global Network.